Cited by 339Phytochemicals and Medicinal PlantsMedicinal Plants and NeuroprotectionNerve injury and regeneration

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Neuritic regeneration and synaptic reconstruction induced by withanolide A

Open access

Kuboyama, Tomoharu, Tohda, Chihiro, Komatsu, Katsuko·2005·British Journal of Pharmacology

DOI 10.1038/sj.bjp.0706122PMC PMC1576076

Open this paper in CoChat — free account Open PDF

Abstract

We investigated whether withanolide A (WL-A), isolated from the Indian herbal drug Ashwagandha (root of Withania somnifera), could regenerate neurites and reconstruct synapses in severely damaged neurons. We also investigated the effect of WL-A on memory-deficient mice showing neuronal atrophy and synaptic loss in the brain. Axons, dendrites, presynapses, and postsynapses were visualized by immunostaining for phosphorylated neurofilament-H (NF-H), microtubule-associated protein 2 (MAP2), synaptophysin, and postsynaptic density-95 (PSD-95), respectively. Treatment with A beta(25-35) (10 microM) induced axonal and dendritic atrophy, and pre- and postsynaptic loss in cultured rat cortical neurons. Subsequent treatment with WL-A (1 microM) induced significant regeneration of both axons and dendrites, in addition to the reconstruction of pre- and postsynapses in the neurons. WL-A (10 micromol kg(-1) day(-1), for 13 days, p.o.) recovered A beta(25-35)-induced memory deficit in mice. At that time, the decline of axons, dendrites, and synapses in the cerebral cortex and hippocampus was almost recovered. WL-A is therefore an important candidate for the therapeutic treatment of neurodegenerative diseases, as it is able to reconstruct neuronal networks.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0706122

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Retracted:Nootropic‐like effect of ashwagandha (Withania somnifera L.) in mice
Dhuley, J. N. (2001) · Phytotherapy Research · doi:10.1002/ptr.874 · Cited by 85
Retracted
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Neurotrophins regulate dendritic growth in developing visual cortex
McAllister, A. K., Lo, D. C., & Katz, L. C. (1995) · Neuron · doi:10.1016/0896-6273(95)90171-x · Cited by 959
Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity
Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction
Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 530
Assembly of New Individual Excitatory Synapses
Friedman, H., Bresler, T., Garner, C. C., & Ziv, N. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)00009-x · Cited by 499
Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I. M., Becker, G. W., & Brems, D. N. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10007-2 · Cited by 371

Show all 45 references

Sorted by citations

Withania somnifera: an Indian ginseng
Kulkarni, S. K., & Dhir, A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.011 · Cited by 416
Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver
Sehgal, N., Gupta, A., Valli, R. K., Joshi, S. D., Mills, J. T., Hamel, E., Khanna, P., Jain, S. C., Thakur, S. S., & Ravindranath, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112209109 · Cited by 390
Natural withanolides: an overview
Chen, L.-X., He, H., & Qiu, F. (2011) · Natural Product Reports · doi:10.1039/c0np00045k · Cited by 360
Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects
Paul, S., Chakraborty, S., Anand, U., Dey, S., Nandy, S., Ghorai, M., Saha, S. C., Patil, M. T., Kandimalla, R., Proćków, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112175 · Cited by 306
Search for natural products related to regeneration of the neuronal network
Tohda, C., Kuboyama, T., & Komatsu, K. (2005) · Neurosignals · doi:10.1159/000085384 · Cited by 257
Neuroprotective Herbs for the Management of Alzheimer’s Disease
Gregory, J., Vengalasetti, Y. V., Bredesen, D. E., & Rao, R. V. (2021) · Biomolecules · doi:10.3390/biom11040543 · Cited by 264
Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-κB (NF-κB) activation and NF-κB–regulated gene expression
Ichikawa, H., Takada, Y., Shishodia, S., Bolleddula, J., Nair, M. G., & Aggarwal, B. B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0096 · Cited by 225
Ayurvedic medicinal plants for Alzheimer’s disease: A review
Rao, R. V., Descamps, O., John, V., & Bredesen, D. E. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt125 · Cited by 213
Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging
Singh, R. H., Narsimhamurthy, K., & Singh, G. (2008) · Biogerontology · doi:10.1007/s10522-008-9185-z · Cited by 205
Protective Role of Ashwagandha Leaf Extract and Its Component Withanone on Scopolamine-Induced Changes in the Brain and Brain-Derived Cells
Konar, A., Shah, N., Singh, R., Saxena, N., Kaul, S. C., Wadhwa, R., & Thakur, M. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027265 · Cited by 193
A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice
Malik, F. A., Singh, J., Khajuria, A., Suri, K. A., Satti, N. K., Singh, S., Kaul, M. K., Kumar, A., Bhatia, A., & Qazi, G. N. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.029 · Cited by 193
Withania somnifera L.: Insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective.
Saleem, S., Muhammad, G., Hussain, M. A., Altaf, M., & Bukhari, S. N. A. (2020) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2020.44254.10378 · Cited by 199
Effects of medicinal plants on Alzheimer's disease and memory deficits
Akram, M., & Nawaz, A. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.205108 · Cited by 187
Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)‐induced neurodegeneration
Kuboyama, T., Tohda, C., & Komatsu, K. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04664.x · Cited by 171
Self-citation
Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners.
Wollen, K. A. (2010) · PubMed · Cited by 170
Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics
Peterson, C. T. (2020) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x20957225 · Cited by 160
Establishment of cell suspension cultures of Withania somnifera for the production of withanolide A
Nagella, P., & Murthy, H. N. (2010) · Bioresource Technology · doi:10.1016/j.biortech.2010.03.078 · Cited by 143
Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects
Mandlik, D. S., & Namdeo, A. G. (2020) · Journal of Dietary Supplements · doi:10.1080/19390211.2020.1741484 · Cited by 149
Neurons of the Dopaminergic/Calcitonin Gene-Related Peptide A11 Cell Group Modulate Neuronal Firing in the Trigeminocervical Complex: An Electrophysiological and Immunohistochemical Study
Charbit, A. R., Akerman, S., Holland, P. R., & Goadsby, P. J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2887-09.2009 · Cited by 139
Natural Withanolides in the Treatment of Chronic Diseases
White, P. T., Subramanian, C., Motiwala, H. F., & Cohen, M. S. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-41334-1_14 · Cited by 139
Ayurvedic Medicine for the Treatment of Dementia: Mechanistic Aspects
Farooqui, A. A., Farooqui, T., Madan, A., Ong, J. H.-J., & Ong, W. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/2481076 · Cited by 144
Ashwagandha in brain disorders: A review of recent developments
Zahiruddin, S., Basist, P., Parveen, A., Parveen, R., Khan, W., Gaurav, G., & Ahmad, S. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112876 · Cited by 157
Withanolide A is inherently de novo biosynthesized in roots of the medicinal plant Ashwagandha (Withania somnifera)
Sangwan, R. S., Chaurasiya, N. D., Lal, P., Misra, L., Tuli, R., & Sangwan, R. S. (2008) · Physiologia Plantarum · doi:10.1111/j.1399-3054.2008.01076.x · Cited by 132
Ashwagandha (Withania somnifera) Reverses β-Amyloid1-42 Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND)
Kurapati, K. R. V., Atluri, V. S. R., Samikkannu, T., & Nair, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077624 · Cited by 130
Effects of Ashwagandha (Roots of Withania somnifera) on Neurodegenerative Diseases
Kuboyama, T., Tohda, C., & Komatsu, K. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00022 · Cited by 127
Neurotrophic Natural Products: Chemistry and Biology
Xu, J., Lacoske, M. H., & Theodorakis, E. A. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302268 · Cited by 124
Antioxidant Therapeutic Strategies in Neurodegenerative Diseases
Morén, C., deSouza, R. M., Giraldo, D. M., & Uff, C. E. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169328 · Cited by 129
Anticancer activities ofWithania somnifera: Current research, formulations, and future perspectives
Rai, M., Jogee, P. S., Agarkar, G., & dos Santos, C. A. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1027778 · Cited by 121
Randomized Placebo-Controlled Adjunctive Study of an Extract ofWithania somniferafor Cognitive Dysfunction in Bipolar Disorder
Chengappa, K. N. R., Bowie, C. R., Schlicht, P. J., Fleet, D., Brar, J. S., & Jindal, R. D. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08413 · Cited by 125
Enhanced Biosynthesis of Withanolides by Elicitation and Precursor Feeding in Cell Suspension Culture of Withania somnifera (L.) Dunal in Shake-Flask Culture and Bioreactor
Sivanandhan, G., Selvaraj, N., Ganapathi, A., & Manickavasagam, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104005 · Cited by 119
Withanolide A Biogeneration in in Vitro Shoot Cultures of Ashwagandha (Withania somnifera DUNAL), a Main Medicinal Plant in Ayurveda
Sangwan, R. S., Chaurasiya, N. D., Lal, P., Misra, L., Uniyal, G. C., Tuli, R., & Sangwan, R. S. (2007) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.55.1371 · Cited by 118
Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract
Choudhary, D., Bhattacharyya, S., & Joshi, K. S. (2016) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587216641830 · Cited by 132
Withanolide biosynthesis recruits both mevalonate and DOXP pathways of isoprenogenesis in Ashwagandha Withania somnifera L. (Dunal)
Chaurasiya, N. D., Sangwan, N. S., Sabir, F., Misra, L., & Sangwan, R. S. (2012) · Plant Cell Reports · doi:10.1007/s00299-012-1302-4 · Cited by 115
Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus
Tohda, C., Tamura, T., Matsuyama, S., & Komatsu, K. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706865 · Cited by 116
Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology
Uddin, M. S., Mamun, A. A., Kabir, M. T., Jakaria, M., Mathew, B., Barreto, G. E., & Ashraf, G. M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1420-2 · Cited by 110
Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment
Mehla, J., Gupta, P., Pahuja, M., Diwan, D., & Diksha, D. (2020) · Brain Sciences · doi:10.3390/brainsci10120964 · Cited by 108
Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: Combinational approach for enhanced differentiation
Shah, N., Kataria, H., Kaul, S. C., Ishii, T., Kaur, G., & Wadhwa, R. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01236.x · Cited by 109
Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetics after oral administration of Withania somnifera aqueous extract
Patil, D., Gautam, M., Mishra, S. K., Suresh, K., Gairola, S., Jadhav, S. S., Pawar, S., & Patwardhan, B. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.03.001 · Cited by 108
Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview
Kurapati, K. R. V., Atluri, V. S. R., Samikkannu, T., Garcia, G., & Nair, M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01444 · Cited by 110
A Decade of Molecular Understanding of Withanolide Biosynthesis and In vitro Studies in Withania somnifera (L.) Dunal: Prospects and Perspectives for Pathway Engineering
Dhar, N., Razdan, S., Rana, S., Bhat, W. W., Vishwakarma, R. A., & Lattoo, S. K. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.01031 · Cited by 105
Icariin improves memory impairment in Alzheimer's disease model mice (5xFAD) and attenuates amyloid β‐induced neurite atrophy
Urano, T., & Tohda, C. (2010) · Phytotherapy Research · doi:10.1002/ptr.3183 · Cited by 103
Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management
Saggam, A., Limgaokar, K., Borse, S., Chavan, P., Dixit, S., Tillu, G. S., & Patwardhan, B. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.623795 · Cited by 99
Withanolides and Related Steroids
Misico, R. I., Nicotra, V. E., Oberti, J. C., Barboza, G. E., Gil, R. R., & Burton, G. (2011) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-7091-0748-5_3 · Cited by 99
Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs
Thakral, S., Yadav, A., Singh, V., Kumar, M., Kumar, P., Narang, R., Sudhakar, K., Verma, A., Khalilullah, H., Jaremko, M., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101960 · Cited by 103
Selective killing of cancer cells by leaf extract of Ashwagandha: Components, activity and pathway analyses
Widodo, N., Takagi, Y., Shrestha, B. G., Ishii, T., Kaul, S. C., & Wadhwa, R. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.037 · Cited by 96
Effects of Ashwagandha (Withania somnifera) on Physical Performance: Systematic Review and Bayesian Meta-Analysis
Bonilla, D. A., Moreno, Y., Gho, C., Petro, J. L., Odriozola-Martínez, A., & Kreider, R. B. (2021) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk6010020 · Cited by 106
Withania somnifera root extract ameliorates hypobaric hypoxia induced memory impairment in rats
Baitharu, I., Jain, V., Deep, S. N., Barhwal, K. K., Hota, S. K., Prasad, D. N., & Ilavazhagan, G. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.10.063 · Cited by 94
Ashwagandha (Withania somnifera): Role in Safeguarding Health, Immunomodulatory Effects, Combating Infections and Therapeutic Applications: A Review
Tiwari, R., Chakrabort, S., Saminathan, M., Dhama, K., & Singh, S. V. (2014) · Journal of Biological Sciences · doi:10.3923/jbs.2014.77.94 · Cited by 93
A Systematic Strategy for Discovering a Therapeutic Drug for Alzheimer’s Disease and Its Target Molecule
Yang, Z., Kuboyama, T., & Tohda, C. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00340 · Cited by 90
Endophytes of Withania somnifera modulate in planta content and the site of withanolide biosynthesis
Pandey, S. S., Singh, S., Pandey, H., Srivastava, M., Ray, T., Soni, S. K., Pandey, A., Shanker, K., Babu, C. S. V., Banerjee, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23716-5 · Cited by 91
Withanolide A and Asiatic Acid Modulate Multiple Targets Associated with Amyloid-β Precursor Protein Processing and Amyloid-β Protein Clearance
Patil, S. P., Maki, S., Khedkar, S. A., Rigby, A. C., & Chan, C. (2010) · Journal of Natural Products · doi:10.1021/np900633j · Cited by 92
Water Extract of Ashwagandha Leaves Has Anticancer Activity: Identification of an Active Component and Its Mechanism of Action
Wadhwa, R., Singh, R., Gao, R., Shah, N., Widodo, N., Nakamoto, T., Ishida, Y., Terao, K., & Kaul, S. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077189 · Cited by 90
Chemistry and pharmacology of withania somnifera: An update
Kumar, V., Dey, A., Hadimani, M. B., Marcović, T., & Emerald, M. (2015) · TANG [HUMANITAS MEDICINE] · doi:10.5667/tang.2014.0030 · Cited by 100
Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
Limanaqi, F., Biagioni, F., Busceti, C. L., Ryskalin, L., Polzella, M., Frati, A., & Fornai, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133274 · Cited by 87
In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β‐amyloid(1–42)‐induced cytotoxicity in differentiated PC12 cells
Kumar, S., Seal, C. J., Howes, M. R., Kite, G. C., & Okello, E. J. (2010) · Phytotherapy Research · doi:10.1002/ptr.3261 · Cited by 84
Effects of macroelements and nitrogen source on biomass accumulation and withanolide-A production from cell suspension cultures of Withania somnifera (L.) Dunal
Nagella, P., & Murthy, H. N. (2010) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-010-9799-0 · Cited by 82
Withaferin A modulates the Spindle Assembly Checkpoint by degradation of Mad2–Cdc20 complex in colorectal cancer cell lines
Das, T., Roy, K. S., Chakrabarti, T., Mukhopadhyay, S., & Roychoudhury, S. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.022 · Cited by 79
Potential therapeutic agents against Alzheimer’s disease from natural sources
Park, S. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1010-y · Cited by 79
Investigating 11 Withanosides and Withanolides by UHPLC–PDA and Mass Fragmentation Studies from Ashwagandha ( Withania somnifera )
Girme, A., Saste, G., Pawar, S., Balasubramaniam, A. K., Musande, K., Darji, B., Satti, N. K., Verma, M. K., Anand, R., Singh, R., et al. (2020) · ACS Omega · doi:10.1021/acsomega.0c03266 · Cited by 81
Withanolide A offers neuroprotection, ameliorates stress resistance and prolongs the life expectancy of Caenorhabditis elegans
Akhoon, B. A., Pandey, S., Tiwari, S., & Pandey, R. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.03.004 · Cited by 78
Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity
Kataria, H., Wadhwa, R., Kaul, S. C., & Kaur, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037080 · Cited by 77
Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease
Singh, S. P., Nand, S., Maurya, A., Mishra, G., Awasthi, R., Shakya, A., Chellappan, D. K., Dua, K., Vamanu, E., Chaudhary, S. K., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5578574 · Cited by 77
Selective Th1 up-regulating activity of Withania somnifera aqueous extract in an experimental system using flow cytometry
Bani, S., Gautam, M., Sheikh, F. A., Khan, B., Satti, N. K., Suri, K. A., Qazi, G. N., & Patwardhan, B. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.02.016 · Cited by 73
Circadian Pattern of Melatonin MT1 and MT2 Receptor Localization in the Rat Suprachiasmatic Nucleus
Waly, N. E., & Hallworth, R. (2015) · Journal of Circadian Rhythms · doi:10.5334/jcr.ab · Cited by 73
Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster
Manjunath, M. J., & Muralidhara (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-013-1219-0 · Cited by 69
Withania somnifera (Linn.) Dunal: a review of chemical and pharmacological diversity
Kalra, R., & Kaushik, N. (2017) · Phytochemistry Reviews · doi:10.1007/s11101-017-9504-6 · Cited by 69
Extracellular vimentin interacts with insulin-like growth factor 1 receptor to promote axonal growth
Shigyo, M., Kuboyama, T., Sawai, Y., Tada-Umezaki, M., & Tohda, C. (2015) · Scientific Reports · doi:10.1038/srep12055 · Cited by 65
Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity
Khan, S., Malik, F. A., Suri, K. A., & Singh, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.011 · Cited by 63
Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET
Tohda, C., & Joyashiki, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00313.x · Cited by 62
Characterization of Anti-neurodegenerative Effects of Polygala tenuifolia in A.BETA.(25-35)-Treated Cortical Neurons
Naito, R., & Tohda, C. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1892 · Cited by 61
Biology‐Oriented Synthesis of a Withanolide‐Inspired Compound Collection Reveals Novel Modulators of Hedgehog Signaling
Švenda, J., Sheremet, M., Kremer, L., Maier, L., Bauer, J. O., Carsten Strohmann, B., Ziegler, S., Kumar, K., & Waldmann, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500112 · Cited by 62
Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component
Dar, P. A., Singh, L. R., Kamal, M. A., & Dar, T. A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151125001751 · Cited by 61
Traditional Herbal Medicines Against CNS Disorders from Bangladesh
Uddin, M. J., & Zidorn, C. (2020) · Natural Products and Bioprospecting · doi:10.1007/s13659-020-00269-7 · Cited by 66
Bioactive Compound Collections: From Design to Target Identification
Laraia, L., Robke, L., & Waldmann, H. (2018) · Chem · doi:10.1016/j.chempr.2018.01.012 · Cited by 61
Computational Evidence to Inhibition of Human Acetyl Cholinesterase by Withanolide A for Alzheimer Treatment
Grover, A., Shandilya, A., Agrawal, V., Bisaria, V. S., & Sundar, D. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.10507408 · Cited by 60
Withanolides: Phytoconstituents with significant pharmacological activities
Singh, A., Duggal, S., Singh, H., Singh, J., & Katekhaye, S. D. (2010) · International Journal of Green Pharmacy · doi:10.4103/0973-8258.74130 · Cited by 59
A novel compound, denosomin, ameliorates spinal cord injury via axonal growth associated with astrocyte‐secreted vimentin
Teshigawara, K., Kuboyama, T., Shigyo, M., Nagata, A., Sugimoto, K., Matsuya, Y., & Tohda, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02211.x · Cited by 59
Active components from Siberian ginseng (Eleutherococcus senticosus) for protection of amyloid β(25–35)-induced neuritic atrophy in cultured rat cortical neurons
Bai, Y., Tohda, C., Zhu, S., Hattori, M., & Komatsu, K. (2011) · Journal of Natural Medicines · doi:10.1007/s11418-011-0509-y · Cited by 58
Pharmacological exploration of traditional plants for the treatment of neurodegenerative disorders
Wahid, M., Ali, A., Saqib, F., Aleem, A., Bibi, S., Afzal, K., Ali, A., Baig, A., Khan, S. A., & Asad, M. H. H. B. (2020) · Phytotherapy Research · doi:10.1002/ptr.6742 · Cited by 61
Synthesis of Withanolide A, Biological Evaluation of Its Neuritogenic Properties, and Studies on Secretase Inhibition
Jana, C. K., Hoecker, J., Woods, T. M., Jessen, H. J., Neuburger, M. A., & Gademann, K. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101869 · Cited by 57
Withania somnifera (L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review
Lerose, V., Ponticelli, M., Benedetto, N., Carlucci, V., Lela, L., Tzvetkov, N. T., & Milella, L. (2024) · Plants · doi:10.3390/plants13060771 · Cited by 66
Role of medicinal plants against Alzheimer’s disease
Roy, A. (2018) · International Journal of Complementary & Alternative Medicine · doi:10.15406/ijcam.2018.11.00398 · Cited by 55
Attenuation of Glutamate-Induced Excitotoxicity by Withanolide-A in Neuron-Like Cells: Role for PI3K/Akt/MAPK Signaling Pathway
Dar, N. J., Satti, N. K., Dutt, P., Hamid, A., & Ahmad, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0515-5 · Cited by 57
The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by ß‐amyloid peptide
Kurz, C., Ungerer, I., Lipka, U., Kirr, S., Schütt, T., Eckert, A., Leuner, K., & Müller, W. E. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00656.x · Cited by 55
Improved Agrobacterium rhizogenes-mediated hairy root culture system of Withania somnifera (L.) Dunal using sonication and heat treatment
Thilip, C., Raju, C. S., Varutharaju, K., Aslam, A., & Shajahan, A. (2015) · 3 Biotech · doi:10.1007/s13205-015-0297-2 · Cited by 54
Glioprotective Effects of Ashwagandha Leaf Extract against Lead Induced Toxicity
Kumar, P., Singh, R. P., Nazmi, A., Lakhanpal, D., Kataria, H., & Kaur, G. (2014) · BioMed Research International · doi:10.1155/2014/182029 · Cited by 53
Withania somnifera leaf alleviates cognitive dysfunction by enhancing hippocampal plasticity in high fat diet induced obesity model
Manchanda, S., & Kaur, G. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1652-0 · Cited by 53
Neuroprotective effects of Withania somnifera in the SH-SY5Y Parkinson cell model
Wongtrakul, J., Thongtan, T., Kumrapich, B., Saisawang, C., & Ketterman, A. J. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08172 · Cited by 52
Ashwagandha
Bharti, V. K., Malik, J. K., & Gupta, R. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00052-8 · Cited by 53
Evaluation of the bioavailability of major withanolides of Withania somnifera using an in vitro absorption model system
Bodhankar, S. L., Devkar, S. T., Kandhare, A. D., Sloley, B. D., Jagtap, S., Lin, J. C., Tam, Y., Katyare, S. S., & Hegde, M. (2015) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/2231-4040.165023 · Cited by 51
Cytotoxicity of withanolides isolated from Acnistus arborescens
Camacho, C. P. C., Morantes, S. J., Páez, A., Rincón, J., & Aristizábal, F. (2009) · Fitoterapia · doi:10.1016/j.fitote.2009.05.011 · Cited by 51
Biotechnological interventions inWithania somnifera(L.) Dunal
Singh, P., Guleri, R., Singh, V., Kaur, G., Kataria, H., Singh, B. B., Kaur, G., Kaul, S. C., Wadhwa, R., & Pati, P. K. (2015) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2015.1020467 · Cited by 51
M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania somnifera
Konar, A., Gupta, R., Shukla, R. K., Maloney, B., Khanna, V. K., Wadhwa, R., Lahiri, D. K., & Thakur, M. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-48238-6 · Cited by 53
Oxidative Stress Induced NMDA Receptor Alteration Leads to Spatial Memory Deficits in Temporal Lobe Epilepsy: Ameliorative Effects of Withania somnifera and Withanolide A
Soman, S. K., Korah, P. K., Jayanarayanan, S., Mathew, J., & Paulose, C. S. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0810-5 · Cited by 50
Kamikihi-to (KKT) Rescues Axonal and Synaptic Degeneration Associated with Memory Impairment in a Mouse Model of Alzheimer's Disease, 5XFAD
Tohda, C., Nakada, R., Urano, T., Okonogi, A., & Kuboyama, T. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.602809 · Cited by 50
Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease
Kalra, J., & Khan, A. G. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.043 · Cited by 47
Inhibitory Effects of Eleutherococcus senticosus Extracts on Amyloid β(25-35)–Induced Neuritic Atrophy and Synaptic Loss
Tohda, C., Ichimura, M., Bai, Y., Tanaka, K., Zhu, S., & Komatsu, K. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08046fp · Cited by 48
Morphology and withanolide production of Withania coagulans hairy root cultures
Mirjalili, H. M., Fakhr-Tabatabaei, S. M., Bonfill, M., Alizadeh, H., Cusido, R. M., Ghassempour, A., & Palazón, J. (2009) · Engineering in Life Sciences · doi:10.1002/elsc.200800081 · Cited by 47
Effect of Withania somnifera Supplementation on Rotenone-Induced Oxidative Damage in Cerebellum and Striatum of the Male Mice Brain
Manjunath, M. J., & ., M. (2013) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524911313010007 · Cited by 45
Withania somnifera Water Extract as a Potential Candidate for Differentiation Based Therapy of Human Neuroblastomas
Kataria, H., Wadhwa, R., Kaul, S. C., & Kaur, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055316 · Cited by 45

Authors: Kuboyama, T., Tohda, C., & Komatsu, K.
Affiliations: University of Toyama (JP)
Institute of Natural Medicine, University of Toyama (JP)
Corresponding author: Komatsu, Katsuko
ORCID: Kuboyama, Tomoharu
Tohda, Chihiro
Komatsu, Katsuko
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2005-04
Volume: 144
Issue: 7
Pages: 961-971
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1038/sj.bjp.0706122
PMC: PMC1576076
OpenAlex: W2062620653
Cited by: 339
References: 45
Citations by year: 2026: 17 · 2025: 12 · 2024: 21 · 2023: 25 · 2022: 20 · 2021: 21 · 2020: 21 · 2019: 11 · 2018: 19 · 2017: 22 · 2016: 20 · 2015: 23 · 2014: 16 · 2013: 21 · 2012: 15
FWCI: 17.90
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 1399 d)
Locations: British Journal of Pharmacology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords: withanolide A, Withania somnifera, neurite regeneration, axonal atrophy, dendritic atrophy, synaptic loss, amyloid beta 25-35, memory impairment, neurodegenerative diseases, neurofilament H, synaptophysin, PSD-95, cortical neurons, hippocampus, neuroprotection
MeSH terms: Animals, Cells, Cultured, Female, Nerve Regeneration, Plant Extracts, Pregnancy, Synapses, Neurites, Rats, Sprague-Dawley, Plant Roots, Withania, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuritic regeneration and synaptic reconstruction induced by withanolide A

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks